![Matej Mikulic](https://cdn.statcdn.com/static/../CMS/contactperson/ERI285_1713877581.png)
Likelihood of outsourcing a clinical trial completely or partially 2022
According to a survey conducted in 2022, almost half of biopharma executives stated that over the past two years it had become more likely that their company outsources a portion of a clinical trial. This statistic describes the change in likelihood over the past two years of outsourcing a clinical trial completely or partially among biopharmaceutical companies around the world.